B+
Bull case
25%
Probability
Target price
$3.80
+61.7% vs current
CCLD
CareCloudCNasdaq / Health Care Equipment & Services
Last Price
At close
2026-06-03
AI scenario view
RankAlpha Sentiment CodexPost-earnings T+3Most likely
B
Base case
50%
Probability
Target price
$2.60
+10.6% vs current
B-
Bear case
25%
Probability
Target price
$1.60
-31.9% vs current
AI sentiment snapshot
Latest data as of 2026-05-09
Recent news sentiment (30D)
-26.5
Negative
Company
-
Unavailable
Macro
-26.5
Negative
Pulse
-
Unavailable
Sentiment proxy
+59.7
Score
AI commentary
This remains a cautious monitoring setup. The deterministic prior moved to neutral, evidence quality is only moderate, and the stock reaction after the May 7, 2026 earnings release was not confirming: by the latest May 9, 2026 market snapshot, CCLD was about 4.5% below the prior close at $2.36 versus $2.47. That suggests the market is waiting for cleaner proof that revenue growth, AI launches, and preferred-stock redemption translate into better earnings quality and a sturdier balance sheet. T+3 analyst revision evidence was limited, so the lack of visible follow-through keeps conviction restrained rather than improved.
RankAlpha Sentiment Codex - 2026-05-09
Open post-earnings memoEvidence flagged
No evidence quality warning is currently attached to this memo.
Impact
standard
Confidence
-
AI events
2026-05-15eventSeries B preferred redemption on May 15 is the clearest hard catalystHigh impact
The Q1 earnings release said CareCloud reaffirmed guidance after closing a $50 million credit facility and scheduling redemption of 100% of its Series B preferred stock for May 15, 2026. A clean redemption would simplify the capital structure and remove the preferred overhang, but investors will then refocus on leverage, covenant discipline, and whether lower preferred-cost pressure is merely replaced by debt-service pressure [#8-K-2026-05-07].
2026-05-19catalystMay 19 Analyst Day is the next near-term proof point for the AI and inpatient expansion narrativeHigh impact
CareCloud said it will host a May 19, 2026 Analyst Day alongside a Nasdaq closing-bell event, where management plans a business update and new AI product showcase. After a muted post-Q1 stock reaction, this is the next near-term checkpoint for whether management can turn the Q1 revenue-growth and AI-launch story into a more credible forward narrative.
2026-12-31catalystReaffirmed 2026 guidance needs margin follow-through after Medsphere transition costsHigh impact
CareCloud reported Q1 2026 revenue of $31.3 million, adjusted EBITDA of $5.4 million, and reaffirmed full-year 2026 guidance for $128-$132 million of revenue, $29-$31 million of adjusted EBITDA, and $0.20-$0.23 of GAAP EPS. Management said Q1 earnings were depressed by temporary Medsphere integration and amortization costs that should ease, but the 10-Q still showed only $3.4 million of cash at March 31 and continued integration-related complexity, so the longer thesis still depends on converting AI launches and inpatient expansion into cleaner margins and cash generation over the balance of 2026 [#8-K-2026-05-07][#10-Q-2026-05-07].
Recommendation
N/A
No formal recommendation provided.
As of 2026-05-09 • Updated nightlySource: Internal modelMethodology